Back to Authors

Leporé, Natasha

https://orcid.org/0000-0002-8379-674X

Mayo Clinic

Children's Hospital of Los Angeles

Citations 5

nnMobileNet: Rethinking CNN for Retinopathy Research
Zhu, Wenhui , Chen, Xiwen , Leporé, Natasha , Dumitrascu, Oana M. , Qiu, Peijie , Li, Xin , Wang, Yalin

2024 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW) | September 27, 2024 | Volume: No volume available | Issue: No issue available | Pages: 2285-2294

10.1109/cvprw63382.2024.00234 Get It

Pre-Training Graph Attention Convolution for Brain Structural Imaging Biomarker Analysis and Its Application to Alzheimer’s Disease Pathology Identification
Yang, Zhangsihao , Farazi, Mohammad , Zhu, Wenhui , Chen, Yanxi , Reiman, Eric M. , Caselli, Richard J., Leporé, Natasha , Su, Yi , Rouhi, Rahimeh , Caselli, Richard J. , Chen, Kewei , Wang, Yalin

2024 IEEE International Symposium on Biomedical Imaging (ISBI) | August 22, 2024 | Volume: No volume available | Issue: No issue available | Pages: 1-5

10.1109/isbi56570.2024.10635797 Get It

Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding
Wu, Jianfeng , Initiative, for the Alzheimer’s Disease Neuroimaging, Zhu, Wenhui , Mallak, Negar Jalili , Leporé, Natasha , Reiman, Eric M. , Caselli, Richard J., Thompson, Paul M. , Thompson, Paul M , Initiative, for the Alzheimer’s Disease Neuroimaging, Su, Yi , Caselli, Richard J. , Chen, Kewei , Wang, Yalin

Journal of Alzheimer's Disease | November 29, 2022 | Volume: 91 | Issue: 2 | Pages: 637-651

10.3233/jad-220812 Get It

Background: Amyloid-β (Aβ) plaques and tau protein tangles in the brain are the defining ‘A’ and ‘T’ hallmarks of Alzheimer’s disease (AD), and together with structural atrophy detectable on brain magnetic resonance imaging (MRI) scans as one of the neurodegenerative (‘N’) biomarkers comprise the “ATN framework” of AD. Current methods to detect Aβ/tau pathology include cerebrospinal fluid (invasive), positron emission tomography (PET; costly and not widely available), and blood-based biomarkers (promising but mainly still in development). Objective: To develop a non-invasive and widely available structural MRI-based framework to quantitatively predict the amyloid and tau measurements. Methods: With MRI-based hippocampal multivariate morphometry statistics (MMS) features, we apply our Patch Analysis-based Surface Correntropy-induced Sparse coding and max-pooling (PASCS-MP) method combined with the ridge regression model to individual amyloid/tau measure prediction. Results: We evaluate our framework on amyloid PET/MRI and tau PET/MRI datasets from the Alzheimer’s Disease Neuroimaging Initiative. Each subject has one pair consisting of a PET image and MRI scan, collected at about the same time. Experimental results suggest that amyloid/tau measurements predicted with our PASCP-MP representations are closer to the real values than the measures derived from other approaches, such as hippocampal surface area, volume, and shape morphometry features based on spherical harmonics. Conclusion: The MMS-based PASCP-MP is an efficient tool that can bridge hippocampal atrophy with amyloid and tau pathology and thus help assess disease burden, progression, and treatment effects.
Integrating Convolutional Neural Networks and Multi-Task Dictionary Learning for Cognitive Decline Prediction with Longitudinal Images
Dong, Qunxi , Zhang, Jie , Li, Qingyang , Wang, Junwen , Leporé, Natasha , Caselli, Richard J. , Ye, Jieping , Wang, Yalin , Initiative, for the Alzheimer’s Disease Neuroimaging, Wang, Junwen , Wang, Yalin , Thompson, Paul M. , Initiative, for the Alzheimer’s Disease Neuroimaging

Journal of Alzheimer’s Disease | May 8, 2020 | Volume: 75 | Issue: 3 | Pages: 971-992

10.3233/jad-190973 Get It

Background: Disease progression prediction based on neuroimaging biomarkers is vital in Alzheimer’s disease (AD) research. Convolutional neural networks (CNN) have been proved to be powerful for various computer vision research by refining reliable and high-level feature maps from image patches. Objective: A key challenge in applying CNN to neuroimaging research is the limited labeled samples with high dimensional features. Another challenge is how to improve the prediction accuracy by joint analysis of multiple data sources (i.e., multiple time points or multiple biomarkers). To address these two challenges, we propose a novel multi-task learning framework based on CNN. Methods: First, we pre-trained CNN on the ImageNet dataset and transferred the knowledge from the pre-trained model to neuroimaging representation. We used this deep model as feature extractor to generate high-level feature maps of different tasks. Then a novel unsupervised learning method, termed Multi-task Stochastic Coordinate Coding (MSCC), was proposed for learning sparse features of multi-task feature maps by using shared and individual dictionaries. Finally, Lasso regression was performed on these multi-task sparse features to predict AD progression measured by the Mini-Mental State Examination (MMSE) and the Alzheimer’s Disease Assessment Scale cognitive subscale (ADAS-Cog). Results: We applied this novel CNN-MSCC system on the Alzheimer’s Disease Neuroimaging Initiative dataset to predict future MMSE/ADAS-Cog scales. We found our method achieved superior performances compared with seven other methods. Conclusion: Our work may add new insights into data augmentation and multi-task deep model research and facilitate the adoption of deep models in neuroimaging research.
Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface‐based Alzheimer's disease neuroimaging initiative study
Shi, Jie , Leporé, Natasha , Thompson, Paul M. , Baxter, Leslie C. , Caselli, Richard J., Wang, Yalin , Initiative, for the Alzheimer's Disease Neuroimaging, Gutman, Boris A , Baxter, Leslie C. , Caselli, Richard J. , Initiative, for the Alzheimer's Disease Neuroimaging, Thompson, Paul M , Wang, Yalin

Human Brain Mapping | January 22, 2014 | Volume: 35 | Issue: 8 | Pages: 3903-3918

10.1002/hbm.22447 Get It

AbstractThe apolipoprotein E (APOE) e4 allele is the most prevalent genetic risk factor for Alzheimer's disease (AD). Hippocampal volumes are generally smaller in AD patients carrying the e4 allele compared to e4 noncarriers. Here we examined the effect of APOE e4 on hippocampal morphometry in a large imaging database—the Alzheimer's Disease Neuroimaging Initiative (ADNI). We automatically segmented and constructed hippocampal surfaces from the baseline MR images of 725 subjects with known APOE genotype information including 167 with AD, 354 with mild cognitive impairment (MCI), and 204 normal controls. High‐order correspondences between hippocampal surfaces were enforced across subjects with a novel inverse consistent surface fluid registration method. Multivariate statistics consisting of multivariate tensor‐based morphometry (mTBM) and radial distance were computed for surface deformation analysis. Using Hotelling's T2 test, we found significant morphological deformation in APOE e4 carriers relative to noncarriers in the entire cohort as well as in the nondemented (pooled MCI and control) subjects, affecting the left hippocampus more than the right, and this effect was more pronounced in e4 homozygotes than heterozygotes. Our findings are consistent with previous studies that showed e4 carriers exhibit accelerated hippocampal atrophy; we extend these findings to a novel measure of hippocampal morphometry. Hippocampal morphometry has significant potential as an imaging biomarker of early stage AD. Hum Brain Mapp 35:3903–3918, 2014. © 2014 Wiley Periodicals, Inc.